[247] identified a role for histone deacetylase 6 (HDAC6) in iCAFs in programming the immunosuppressive TME, where reducing HDAC6 in CAFs can alter the immunosuppressive breast cancer microenvironment by inhibiting MDSC and Treg recruitment and modulating macrophage phenotypes. Here, HDAC6 is linked to breast cancer.